Chief Executive, British Dental Industry Association, Mineral Lane, Chesham, Buckinghamshire, HP5 1NL, UK.
Br Dent J. 2020 May;228(9):678-680. doi: 10.1038/s41415-020-1583-x.
The COVID-19 situation has seen the cessation of all non-urgent dental care in the UK. Regular practice activity has come to a virtual standstill and the dental industry has seen a very significant reduction in its provision of products and services. There are differing government financial mitigations in place across dental practices for NHS and, to an extent private, activity, as well as for the dental industry. Dentistry is generally classified in the very high-risk category of aerosol production through many aerosol generating procedures (AGPs). To facilitate any move towards the resumption of widespread dental treatment, possibly without mass vaccination or the widespread use of antibody testing, the aerosol issue will need to be addressed and solved. From a dental industry perspective, equipment and product manufacturers and suppliers are building upon, and further developing, the industry's extremely close relationship and partnership with the dental profession, in order to develop and implement new ways of thinking and new approaches, products and techniques to protect patients and clinicians, focusing on a return to the more widespread provision of dentistry.
在英国，COVID-19 疫情已导致所有非紧急牙科护理服务暂停。常规的执业活动已基本停止，牙科行业提供的产品和服务也大幅减少。英国国民保健制度（NHS）和私人执业的牙科机构都采取了不同的政府财政缓解措施，牙科行业也是如此。通过许多气溶胶产生程序（AGPs），牙科通常被归类为气溶胶产生的极高风险类别。为了促进广泛的牙科治疗的恢复，而不必进行大规模的疫苗接种或广泛使用抗体检测，需要解决气溶胶问题。从牙科行业的角度来看，设备和产品制造商及供应商正在进一步发展行业与牙科专业人士的密切关系和伙伴关系，以开发和实施新的思维方式和新方法、产品和技术，以保护患者和临床医生，专注于更广泛地提供牙科服务。
